Statement Of Deviation/Variation For Half Year Ended March, 2025
Filed with BSE · · 3 pages · English
Pursuant to RegulaƟon 32 of the SEBI LisƟng RegulaƟons, read with relevant SEBI Circulars, it is hereby confirmed that there is no deviaƟon or variaƟon in the use of proceeds from the allotment of 8,56,872 warrants as warrant subscripƟon price (25% i.e. Rs. 12.75 per equity warrant), each exercisable into, or exchangeable for, 1 (one) fully paid up equity share of the Company of face value of Rs. 1
Vrundavan Plantation Ltd. on 6ix
Earlier from Vrundavan Plantation
- Statement Of Deviation For Half Year Ended March 31, 2025
- Financial Results For Six Months And Financial Year Ended March 31, 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. May 29, 2025
- Vrundavan Plantation Ltd. Press Release May 21 2025
- Board Meeting Intimation for JFL Life Sciences Limited To Be Held On May 29, 2025
Later from Vrundavan Plantation
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
- Vrundavan Plantation Ltd. Press Release Jun 04 2025
- Board Meeting Outcome for Appointment Of Ms. Shivani Tiwari As Chief Financial Officer Of The Company W.E.F. 05-06-2025
- Vrundavan Plantation Ltd. Press Release Jun 05 2025
- Revised Outcome Of Board Meeting For Results For Half Year And Year Ended March 31, 2025 Along With Declaration Of Unmodified Opinion
Follow Vrundavan Plantation into a list and get an email when it puts out news.
Follow Vrundavan Plantation